Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
NKTR
#1941
Nektar Therapeutics
73.250
0
USD
+4.11%
Sektör:
Sağlık hizmetleri
Baz:
USD
Kar para birimi:
USD
Günlük aralık
Yıllık aralık
Günlük değişim
+4.11%
Aylık değişim
-0.03%
6 aylık değişim
-0.03%
Yıllık değişim
-0.03%
Önceki kapanış
70.360
0
Open
73.250
0
Bid
73.250
0
Ask
73.253
0
Low
73.250
0
High
73.250
0
Hacim
66
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
NKTR
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
12.3 M
12.41 M
12.41 M
19.02 M
20.34 M
—
Valuation ratios
Enterprise value
—
—
—
448.45 M
1.12 B
—
Price to earnings ratio
—
—
—
-2.98
-7.25
—
Price to sales ratio
—
—
—
4.79
13.27
—
Price to cash flow ratio
—
—
—
1.95
4.49
—
Price to book ratio
—
—
—
2.43
4.9
—
Enterprise value to EBITDA ratio
—
—
—
—
-6.24
—
Profitability ratios
Return on assets %
0.12
-0.02
0.2
0.2
0.12
0.49
Return on equity %
0.76
-0.12
3.7
1.72
0.42
5.72
Return on invested capital %
233.59
-106.05
321.82
316.55
297.28
829.6
Gross margin %
81.62
72.66
100
100
100
372.66
Operating margin %
142.37
-49.18
425.76
324.21
268.63
969.43
EBITDA margin %
—
-109.97
-580.57
-406.73
-344.29
-1 441.57
Net margin %
153.61
-24.89
486.44
372.2
301.29
1 135.04
Liquidity ratios
Quick ratio
4.24
4.26
—
—
—
—
Current ratio
4.24
4.26
3.24
2.61
4.24
14.35
Inventory turnover
0.61
—
—
—
—
—
Asset turnover
0.07
0.1
0.04
0.05
0.05
0.23
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
3.15
3.37
3.49
3.25
2.57
12.68
EBIT per share
-2.53
-2.45
-4.41
-3.29
-2.22
-12.37
EBITDA per share
—
-2.34
-4.32
-3.23
-2.14
-12.03
Total debt per share
—
—
—
—
—
—
Cash per share
17.53
18.62
15.55
12.49
14.26
60.91
Net current asset value per share
20.54
19.06
16.35
13.24
14.85
63.5
Tangible book value per share
3.5
4.43
0.98
1.72
4.49
11.62
Working capital per share
15.69
14.58
11.31
8.18
11.35
45.41
Book value per share
3.5
4.43
0.98
1.72
4.49
11.62
Haberler
Oppenheimer, Nektar Therapeutics için hedef fiyatı 140 dolara yükseltti
Oppenheimer raises Nektar Therapeutics price target to $140
Nektar Therapeutics hissesi 76,3 dolarda 52 haftalık zirve yaptı
Nektar Therapeutics stock hits 52-week high at 76.3 USD
Nektar Therapeutics 4Ç 2025 sonuçları: Nakit artışı ve Ar-Ge genişlemesi
Earnings call transcript: Nektar Therapeutics Q4 2025 shows cash boost and R&D expansion
Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) Misses Q4 Earnings Estimates
Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for
Wall Street Analysts Think Nektar (NKTR) Could Surge 89.8%: Read This Before Placing a Bet
Nektar Therapeutics stock hits 52-week high at 75.19 USD
Nektar Therapeutics 460 milyon dolarlık halka arzını tamamladı